Alta Advisers’s Pfizer PFE Stock Holding History

Alta Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$520K	Hold	21,612	–	–	0.12%	86
2026 Q1	$607K	Hold	21,612	–	–	0.22%	69
2025 Q4	$538K	Sell	21,612 -9,400	-30%	-$237K	0.2%	82
2025 Q3	$790K	Sell	31,012 -900	-3%	-$22.2K	0.24%	73
2025 Q2	$774K	Hold	31,912	–	–	0.28%	66
2025 Q1	$809K	Buy	31,912 +13,100	+70%	+$343K	0.34%	59
2024 Q4	$499K	Buy	18,812 +3,012	+19%	+$81.7K	0.32%	61
2024 Q3	$457K	Hold	15,800	–	–	0.21%	62
2024 Q2	$442K	Buy	15,800 +1,100	+7%	+$30.3K	0.21%	53
2024 Q1	$408K	Hold	14,700	–	–	0.2%	59
2023 Q4	$423K	Hold	14,700	–	–	0.23%	49
2023 Q3	$488K	Hold	14,700	–	–	0.28%	37
2023 Q2	$539K	Hold	14,700	–	–	0.3%	32
2023 Q1	$600K	Hold	14,700	–	–	0.36%	28
2022 Q4	$753K	Hold	14,700	–	–	0.45%	24
2022 Q3	$643K	Buy	+14,700	New	+$714K	0.4%	23
2013 Q4	–	Sell	-998	Closed	-$27K	–	69
2013 Q3	$27K	Sell	998 -637	-39%	-$17.3K	0.01%	58
2013 Q2	$43K	Buy	+1,635	New	+$45.2K	0.02%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alta Advisers's PFE Position: Q2 2026 in Review

Alta Advisers held its Pfizer (PFE) position steady in Q2 2026 at 21,612 shares worth $520K. The position accounts for 0.12% of the portfolio, ranked #86.

Alta Advisers first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $809K in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Alta Advisers held 21,612 shares of Pfizer worth $520K as of Q2 2026.
Alta Advisers left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.12% of Alta Advisers's portfolio in Q2 2026, its #86 holding.
Alta Advisers first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
Alta Advisers's Pfizer position peaked at $809K in Q1 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.